Aspira Women's Health gets approval for OvaWatch ovarian cancer test [Yahoo! Finance]
Aspira Women's Health Inc. (AWH)
Last aspira women's health inc. earnings: 4/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
awac.com/ircontent
Company Research
Source: Yahoo! Finance
Laboratory Evaluation Program (CLEP) to market its ovarian cancer test OvaWatch in New York, US. The CLEP approval is a critical step for lab-developed tests, confirming compliance with the state's clinical laboratory regulations. Launched in November 2022, OvaWatch is reported to be the only noninvasive blood test available for evaluating ovarian cancer risk in patients with an adnexal mass initially deemed indeterminate or benign. The test has a 99% negative predictive value and features longitudinal monitoring, enabling physicians and patients to tailor treatment plans. Aspira Women's Health CEO Nicole Sandford said: “We are gratified to have secured CLEP approval for OvaWatch opening the door to one of the nation's largest healthcare markets with over ten million women residing in New York state. “Additionally, with a process that some view as equal to or more stringent than some at the federal level, we believe that CLEP approval provides important validation of the rig
Show less
Read more
Impact Snapshot
Event Time:
AWH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AWH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AWH alerts
High impacting Aspira Women's Health Inc. news events
Weekly update
A roundup of the hottest topics
AWH
News
- Aspira (AWH) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Aspira Women's Health Inc. (NASDAQ: AWH) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Aspira Women’s Health Reports Selected Third Quarter 2024 Financial ResultsGlobeNewswire
- Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect [Yahoo! Finance]Yahoo! Finance
AWH
Earnings
- 11/12/24 - Beat
AWH
Sec Filings
- 11/22/24 - Form 4/A
- 11/19/24 - Form 10-Q
- 11/14/24 - Form 4
- AWH's page on the SEC website